Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activation of Ftorafue [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and gamma-butyrolactone.

× No keyword cloud information.

11 in total

1. Cytotoxicity of three novel fluoropyrimidines in cultured L1210 murine lymphocytic leukemia cells.

Authors: A M Shipp; M H Holshouser; P W Ferguson
Journal: Pharm Res Date: 1990-12 Impact factor: 4.200

2. Stereoselective metabolism of ftorafur (R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil).

Authors: J L Au; W Sadée
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

3. Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma.

Authors: S Kawata; S Noda; Y Imai; S Tamura; R Saitoh; S Miyoshi; Y Minami; S Tarui
Journal: Gastroenterol Jpn Date: 1987-02

Review 4. Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil.

Authors: P M Hoff; Y Lassere; R Pazdur
Journal: Drugs Date: 1999 Impact factor: 9.546

5. A case of allergic liver injury induced by tegafur.

Authors: M Baba; T Shima; T Tanaka; M Nakayabu; H Hasegawa; S Suzuki; I Kusano
Journal: J Gastroenterol Date: 1994-02 Impact factor: 7.527

6. UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.

Authors: Nobutaka Nagai; Keiji Mukai; Eiji Hirata; Hong Hua Jin; Masaaki Komatsu; Mayu Yunokawa
Journal: Med Oncol Date: 2007-10-30 Impact factor: 3.064

Activation of Ftorafue [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and gamma-butyrolactone.

1. Cytotoxicity of three novel fluoropyrimidines in cultured L1210 murine lymphocytic leukemia cells.

2. Stereoselective metabolism of ftorafur (R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil).

3. Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma.

Review 4. Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil.

5. A case of allergic liver injury induced by tegafur.

6. UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.

7. Oral ftorafur plus intramuscular thiotepa as adjuvant chemotherapy in patients with breast cancer.

8. Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy.

9. Pharmacokinetics of ftorafur after intravenous and oral administration.

10. Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.